PT83138B - Processo para a preparacao de esteroides uteis como agentes anti-cancerosos, anti-obesidade, anti-hiperglicemicos, anti-autoimunes e anti-hipercolesterolemicos - Google Patents

Processo para a preparacao de esteroides uteis como agentes anti-cancerosos, anti-obesidade, anti-hiperglicemicos, anti-autoimunes e anti-hipercolesterolemicos

Info

Publication number
PT83138B
PT83138B PT83138A PT8313886A PT83138B PT 83138 B PT83138 B PT 83138B PT 83138 A PT83138 A PT 83138A PT 8313886 A PT8313886 A PT 8313886A PT 83138 B PT83138 B PT 83138B
Authority
PT
Portugal
Prior art keywords
hycercolesterolemic
hyperglycemic
uterine
steroids
obesity
Prior art date
Application number
PT83138A
Other languages
English (en)
Other versions
PT83138A (en
Inventor
Arthur G Schwartz
Marvin Louis Lewbart
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp filed Critical Research Corp
Publication of PT83138A publication Critical patent/PT83138A/pt
Publication of PT83138B publication Critical patent/PT83138B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0025—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016—Oximes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT83138A 1985-08-02 1986-08-04 Processo para a preparacao de esteroides uteis como agentes anti-cancerosos, anti-obesidade, anti-hiperglicemicos, anti-autoimunes e anti-hipercolesterolemicos PT83138B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76258485A 1985-08-02 1985-08-02

Publications (2)

Publication Number Publication Date
PT83138A PT83138A (en) 1986-09-01
PT83138B true PT83138B (pt) 1989-03-30

Family

ID=25065487

Family Applications (1)

Application Number Title Priority Date Filing Date
PT83138A PT83138B (pt) 1985-08-02 1986-08-04 Processo para a preparacao de esteroides uteis como agentes anti-cancerosos, anti-obesidade, anti-hiperglicemicos, anti-autoimunes e anti-hipercolesterolemicos

Country Status (11)

Country Link
EP (1) EP0210665B1 (pt)
JP (1) JP2512439B2 (pt)
AU (1) AU598201B2 (pt)
CA (1) CA1314871C (pt)
DE (1) DE3666437D1 (pt)
DK (1) DK171968B1 (pt)
ES (1) ES2000613A6 (pt)
GR (1) GR862043B (pt)
IE (1) IE58540B1 (pt)
IL (1) IL79583A (pt)
PT (1) PT83138B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60027B1 (en) * 1986-05-21 1994-05-18 Research Corp Steroids useful as anti-cancer and anti-obesity agents
US5175154A (en) * 1987-11-25 1992-12-29 Research Corporation Technologies, Inc. 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds
US5001119A (en) * 1987-11-25 1991-03-19 Schwartz Arthur G 16-substituted androstanes and 16-substituted androstenes
US5028631A (en) * 1987-11-25 1991-07-02 Schwartz Arthur G Homoandrostan-17-one and homoandrosten-17-ones
US4898694A (en) * 1987-11-25 1990-02-06 Schwartz Arthur G 17-Hydroxy-steroids
US5506223A (en) * 1990-08-29 1996-04-09 Humanetics Corporation Δ5-androstenes useful for promoting weight maintenance or weight loss and treatment process
US5585371A (en) * 1990-08-29 1996-12-17 Humanetics Corporation Treatment of immune system with Δ5-androstenes
JP3029907B2 (ja) * 1991-12-20 2000-04-10 理化学研究所 抗肥満剤
US5736537A (en) 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy
ES2156361T5 (es) * 1996-03-29 2012-12-26 Keyvest Gmbh Cosmético o bien composición cosmética para el alisado y la tersura de la piel en el caso de tejido adiposo afectado, en especial en el caso de la "celulitis"
CN103409144B (zh) * 2013-08-16 2014-11-26 东北大学 含甾体基元的环状碳酸酯类活泼液晶单体及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS598074B2 (ja) * 1979-01-23 1984-02-22 沖電気工業株式会社 発光素子アレイ装置
JPS59155140U (ja) * 1983-04-06 1984-10-18 沖電気工業株式会社 光プリントヘツドの組立構造
EP0133995B1 (en) * 1983-08-02 1992-04-15 Research Corporation Technologies, Inc. Steroids and therapeutic compositions containing same
JPS6162016A (ja) * 1984-09-03 1986-03-29 Nhk Spring Co Ltd Ｌｅｄプリンタヘツド

Also Published As

Publication number Publication date
IL79583A (en) 1990-11-29
JP2512439B2 (ja) 1996-07-03
DK368486D0 (da) 1986-08-01
IE862062L (en) 1987-02-02
DK171968B1 (da) 1997-09-01
GR862043B (en) 1986-12-24
ES2000613A6 (es) 1988-03-01
CA1314871C (en) 1993-03-23
IL79583A0 (en) 1986-11-30
PT83138A (en) 1986-09-01
EP0210665B1 (en) 1989-10-18
JPS6248693A (ja) 1987-03-03
DE3666437D1 (en) 1989-11-23
AU6079786A (en) 1987-02-05
AU598201B2 (en) 1990-06-21
IE58540B1 (en) 1993-10-06
DK368486A (da) 1987-02-03
EP0210665A1 (en) 1987-02-04

Similar Documents

Publication Publication Date Title
PT81242B (pt) Processo para a preparacao de lipossomas esteroides
BR8700097A (pt) Processo para a preparacao de 2-oxo-1,3-dioxolanas e seu uso
PT83070B (pt) Processo para a preparacao de novos derivados de avermectina e milbemicina uteis como agentes antiparasiticos
PT83504B (pt) Processo para a preparacao de acrilamidas substituidas
PT81463B (pt) Processo para a preparacao de novos derivados 5-amino-4-hidroxivalerilo
PT83481B (pt) Processo para a preparacao de heteropolissacarideos de baixa viscosidade
PT83389B (pt) Processo para a preparacao de derivados de sulfonilureia uteis como agentes anti-tumurais
BR8501167A (pt) Processo para a preparacao de dinitrotolueno
BR8803152A (pt) Catalisador de desidrogenacao,processo para a preparacao de estireno e estireno
BR8605269A (pt) Processo para preparacao de(2,2)-paraciclofano
PT83138B (pt) Processo para a preparacao de esteroides uteis como agentes anti-cancerosos, anti-obesidade, anti-hiperglicemicos, anti-autoimunes e anti-hipercolesterolemicos
BR8707028A (pt) Processo para a preparacao de mercaptometilfenois
PT83344A (pt) Processo para a preparacao de ypsilon-carbolinas antipsicoticas
PT84072B (pt) Processo para a preparacao de esteroides aminoglicosidicos
BR8502305A (pt) Processo para a preparacao de organopol issiloxanas organofuncionais
BR8505989A (pt) Processo para a preparacao de amino-4-difenilaminas
PT90868A (pt) Processo para a preparacao de novas dibenzo-ciclo-heptenil, ciclo-heptil- e oxapinilaminas utilizaveis como anti-histaminicos
BR8706408A (pt) Processo para a preparacao de aldeidos
BR8605092A (pt) Processo para a preparacao de metacrilamida
PT82837B (pt) Processo para a preparacao de esteroido {3,2-c} pirazois uteis como agentes anti-androgenios
BR8402532A (pt) Processo e dispositivo para a fabricacao de aglutinantes ricos em cal,especialmente cimentos
BR8602094A (pt) Processo para a preparacao de benzotiazolsulfenamidas
PT82323B (pt) Processo para a preparacao de alcanoilanilidas
PT81487B (pt) Processo para a preparacao de novos derivados de tienopiridina
PT80634B (pt) Processo para a preparacao de naftoxacinas

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20050316